CDK1 and familial pancreatic carcinoma: Huang et al. demonstrated that inhibiting CDK1/2/5 can mediate immune cell death and block immune checkpoint expression in pancreatic cancer, which can transform immune cell infiltration of cancers from low to high levels via these two mechanisms, overcoming the immune tolerance induced by interferon therapy (Huang et al., 2021).